Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Ponatinib

2

XII.g Coronary artery disease (acute) - Myocardial ischemia/infarction

1
Last update : 17/04/2014
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Dasatinib
4

Publications

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.
The New England journal of medicine 2013 Nov 07;369;1783-96 2013 Nov 07
Ponatinib pulled off market over safety issues.
Managed care (Langhorne, Pa.) 2013 Dec;22;42-3 2013 Dec

Powered by

  • ^
  • Contact
  • Cookies
  • About